Caxton Associates (New York)’s Avantax, Inc. Common Stock AVTA Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTA
PWAM
NI
Caxton Associates (New York)'s AVTA Position: Q4 2017 in Review
Caxton Associates (New York) sold out of Avantax, Inc. Common Stock (AVTA) in Q4 2017, closing a stake of 15,900 shares — an estimated $402K sold.
Caxton Associates (New York) first reported a position in AVTA in Q1 2017 and held it in 3 quarters. The position peaked at $402K in Q3 2017. 187 funds tracked by Wall St. Rank hold AVTA as of Q4 2017.
- Caxton Associates (New York) reported no remaining Avantax, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
- Caxton Associates (New York) sold 15,900 Avantax, Inc. Common Stock shares in Q4 2017, an estimated $402K.
- Caxton Associates (New York) first reported a position in Avantax, Inc. Common Stock in Q1 2017 and held it in 3 quarters.
- Caxton Associates (New York)'s Avantax, Inc. Common Stock position peaked at $402K in Q3 2017.
- 187 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q4 2017.
Based on Caxton Associates (New York)'s 13F filing for Q4 2017, filed 14 Feb 2018.